Fredrik Jeppsson resigns as CFO of SyntheticMR

SyntheticMR's CFO, Fredrik Jeppsson, has announced after five successful years within the company that he will leave his position after accepting a position in another company.

Fredrik will continue to lead the closing of the 2019 financial year and leaves the company during the first quarter of 2020. The recruitment of a successor has begun.

For additional information, please Ulrik Harrysson, CEO, SyntheticMR AB, +46 70 529 29 87 

SyntheticMR AB develops and markets innovative software solutions for Magnetic Resonance Imaging (MRI). SyntheticMR AB product SyMRI® delivers multiple contrast images and quantitative data from a single 6-minute scan – to improve patient throughput and objective decision support for clinicians. SyMRI is CE-marked and FDA 510(k) cleared. SyMRI is a registered trademark in Europe and in the USA. SyntheticMR is listed on the Spotlight Stock Market in Stockholm, Sweden. For additional information, please visit www.syntheticmr.com. 

This information is information that SyntheticMR AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, on December 10, 2019

Subscribe

Documents & Links